BRIC:LSE:LSE-iShares BRIC 50 UCITS ETF USD (Dist) GBP (GBX)

ETF | Others |

Last Closing

USD 1420.75

Change

0.00 (0.00)%

Market Cap

N/A

Volume

1.60K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-31 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+0.14 (+0.12%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.12 (+0.64%)

USD 557.54B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.01 (+0.09%)

USD 496.18B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.45 (-0.63%)

USD 266.08B
0QZO:LSE 0QZO

+1.60 (+1.80%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.21 (+0.69%)

USD 209.75B
0QZ3:LSE Qualcomm Inc.

+1.37 (+0.83%)

USD 202.26B
0R24:LSE Intel Corp.

+0.42 (+2.15%)

USD 196.14B

ETFs Containing BRIC:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.66% 24% F 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.66% 24% F 34% F
Trailing 12 Months  
Capital Gain -10.74% 9% A- 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.74% 9% A- 21% F
Trailing 5 Years  
Capital Gain -41.18% 6% D- 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -41.18% 6% D- 16% F
Average Annual (5 Year Horizon)  
Capital Gain -10.22% N/A N/A 14% F
Dividend Return -10.08% N/A N/A 14% F
Total Return 0.14% N/A N/A 38% F
Risk Return Profile  
Volatility (Standard Deviation) 18.95% N/A N/A 52% F
Risk Adjusted Return -53.16% N/A N/A 15% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike